Skip to main content
. Author manuscript; available in PMC: 2015 Dec 20.
Published in final edited form as: J Urol. 2014 Aug 9;192(6):1642–1648. doi: 10.1016/j.juro.2014.08.002

Table 3.

Cumulative incidence of patients with disease upgraded by targeted biopsy and those spared MP-MRI by PSA

% Upgraded % Spared MP-MRI PSA (ng/ml)
95 25 4.5
90 36 5.2
85 43 6.0
80 57 7.6
75 61 8.2
70 67 8.9